Loading...
Loading...
HBIO| Name | Value |
|---|---|
| Revenues | 24.5M |
| Cost of Revenue | 11.1M |
| Gross Profit | 13.4M |
| Operating Expense | 14.8M |
| Operating I/L | -1.3M |
| Other Income/Expense | -2.2M |
| Interest Income | 0.0M |
| Pretax | -4.5M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -4.7M |
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for fundamental research, discovery, and pre-clinical testing in the pharmaceutical and biotechnology industries, as well as in academic and government research laboratories. Its product line includes cellular and molecular technology instruments, tissue and organ-based lab research tools, precision scientific measuring instrumentation, and preclinical products. The company markets its offerings through various channels to reach research scientists and organizations, selling under well-known brand names such as Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS.
